FRα overexpression has been observed in several cancers, including breast, lung, gastrointestinal, squamous cell head and neck subsets, endometrial, and ovarian cancer (Figure 2) [3,5,45,46,52,53,54,55,56,57,58,59]. Here, FOLR1 is linked to ovarian cancer.